Please assess the completion status of the following clinical trial:

Trial Title: Aromatase Inhibitors in the Treatment of Male Infertility

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male partner of a couple presenting for infertility work up after one year of unprotected intercourse~2. Moderate oligozoospermia (defined as mean sperm count ≤ 20 × 106/mL and ≥ than 3 × 106/mL) of at least two separate occasions spanning a minimum of two weeks~3. Obese men BMI ≥ 30~4. FSH and LH levels \< 10 mIU/mL~Exclusion Criteria:~1. Severe Oligozoospermia: Sperm count \< than 3 × 106/mL, including azoospermia~2. Age less than 18 or greater than 65 years~3. Pyospermia or leukospermia: defined by white blood cells ≥ 1 million leukocytes per milliliter of semen~4. Cryptorchidism~5. Vasectomy reversal~6. Regular use of tobacco products~7. BMI \< 30~8. Use of anabolic steroids or testosterone replacement~9. All patients with abnormal initial liver function tests AST or ALT will be excluded form the study

- Gender: MALE
- Minimum Age: 16 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Group B (Type: PLACEBO_COMPARATOR): Placebo
- Group A (Type: EXPERIMENTAL): Anastrozole

Based on this trial design, predict the completion outcome and termination type (if applicable).